Non-Hodgkin's Lymphoma

Each year in the United States, more than 66,000 people are diagnosed with non-Hodgkin's lymphoma. Thanks to improvements in treatment, non-Hodgkin's lymphoma patients are living longer. It is estimated that there are more than 400,000 non-Hodgkin's lymphoma survivors living in the U.S. today.

Advances in chemotherapy, targeted therapy, and radiation therapy have all contributed to improved non-Hodgkin's lymphoma survival. In addition, advances in supportive care have made non-Hodgkin's lymphoma treatment more tolerable, leading to improved quality of life.

Understanding non-Hodgkin's lymphoma treatment options, the role of different doctors specializing in the treatment of non-Hodgkin's lymphoma, and how and when to access new and innovative non-Hodgkin's lymphoma treatment options available through clinical trials is essential in order to achieve the best outcome from non-Hodgkin's lymphoma treatment.

The Cancer Consultants Non-Hodgkin's Lymphoma Information Center has been designed to help patients understand non-Hodgkin's lymphoma and non-Hodgkin's lymphoma treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of non-Hodgkin's lymphoma.

Next Section: Overview of Non-Hodgkin's Lymphoma

back to top